Posted by Brian Himes on Mar 18th, 2024
UiPath (NYSE:PATH – Free Report) had its target price lifted by TD Cowen from $25.00 to $28.00 in a research note issued to investors on Thursday, Benzinga reports. The firm currently has an outperform rating on the healthcare...
More of this article »